NASDAQ:AVGR Avinger (AVGR) Stock Price, News & Analysis $0.47 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avinger Stock (NASDAQ:AVGR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Avinger alerts:Sign Up Key Stats Today's Range$0.47▼$0.4750-Day Range$0.47▼$0.4752-Week Range$0.36▼$4.15VolumeN/AAverage Volume1.06 million shsMarket Capitalization$1.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAvinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Read More… Receive AVGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter. Email Address AVGR Stock News HeadlinesAvinger (NASDAQ:AVGR) Coverage Initiated at StockNews.comApril 28, 2025 | americanbankingnews.comAvinger man gets life in prison for 2022 stabbing deathApril 11, 2025 | msn.comIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.May 3, 2025 | Porter & Company (Ad)Redwood City medical device company to liquidate, pay off creditorsFebruary 20, 2025 | bizjournals.comAvinger, Inc. Executes Assignment for the Benefit of Creditors; Announces Receipt of Nasdaq Delisting NoticeFebruary 17, 2025 | globenewswire.comAvinger Inc shareholders approve liquidation planFebruary 6, 2025 | msn.comAvinger Inc's VP of Finance sells $698 in common stockJanuary 25, 2025 | msn.comAvinger CTO Himanshu Patel sells $1,233 in common stockJanuary 25, 2025 | msn.comSee More Headlines AVGR Stock Analysis - Frequently Asked Questions How have AVGR shares performed this year? Avinger's stock was trading at $0.8180 at the start of the year. Since then, AVGR stock has decreased by 42.1% and is now trading at $0.4740. View the best growth stocks for 2025 here. How were Avinger's earnings last quarter? Avinger, Inc. (NASDAQ:AVGR) released its quarterly earnings results on Thursday, November, 7th. The medical device company reported ($1.82) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.03) by $0.21. The medical device company earned $1.65 million during the quarter, compared to analysts' expectations of $1.60 million. Avinger had a negative trailing twelve-month return on equity of 5,527.11% and a negative net margin of 261.06%. Read the conference call transcript. When did Avinger's stock split? Shares of Avinger reverse split on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Avinger IPO? Avinger (AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. How do I buy shares of Avinger? Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avinger investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), GE Aerospace (GE) and Broadcom (AVGO). Company Calendar Last Earnings11/07/2024Today5/03/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:AVGR CIK1506928 Webwww.avinger.com Phone(650) 241-7900Fax800-229-2696Employees70Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($11.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,320,000.00 Net Margins-261.06% Pretax Margin-256.25% Return on Equity-5,527.11% Return on Assets-123.25% Debt Debt-to-Equity RatioN/A Current Ratio1.21 Quick Ratio0.81 Sales & Book Value Annual Sales$7.26 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value($4.53) per share Price / Book-0.10Miscellaneous Outstanding Shares3,309,000Free Float1,893,000Market Cap$1.57 million OptionableNot Optionable Beta1.09 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:AVGR) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.